Given the observation that factor 1 was associated with IGF1R signaling and mTOR inhibitor treatment led to an increase in factor 1 scores, we hypothesized that mTOR inhibition leads to a reactive upregulation of IGF1R signaling in cancer organoids. The gene discussed is MTOR; the disease is cancer.